Acadian Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $505K | Hold |
|
|||||
|
2022
Q3 | $455K | Hold |
|
|||||
|
2022
Q2 | $382K | Buy |
|
|||||
|
2022
Q1 | $797K | Buy |
|
|||||
|
2021
Q4 | $1.23M | Buy |
|
|||||
|
2021
Q3 | $339K | Buy |
|
|||||
|
2021
Q2 | $85K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $0 | Sell |
|
|||||
|
2020
Q2 | $52K | Buy |
|
|||||
|
2020
Q1 | $0 | Sell |
|
|||||
|
2019
Q4 | $145K | Sell |
|
|||||
|
2019
Q3 | $137K | Sell |
|
|||||
|
2019
Q2 | $317K | Buy |
|
|||||
|
2019
Q1 | $385K | Buy |
|
|||||
|
2018
Q4 | $48K | Sell |
|
|||||
|
2018
Q3 | $253K | Buy |
|
|||||
|
2018
Q2 | $208K | Sell |
|
|||||
|
2018
Q1 | $460K | Buy |
|
|||||
|
2017
Q4 | $181K | Buy |
|
|||||
|
2017
Q3 | $25K | Sell |
|
|||||
|
2017
Q2 | $3.47M | Buy |
|
|||||
|
2017
Q1 | $381K | Buy |
|